Servier

Organisation

Trials

  • NCT07028424

    Collaborator, Phase 2, Not yet recruiting, 206 people, 19 Jun 2025

  • NCT06245356

    Collaborator, Phase 2, Recruiting, 73 people, 7 Feb 2024

  • NCT05615818

    Collaborator, Phase 3, Recruiting, 800 people, 14 Nov 2022

  • NCT05476796

    Collaborator, Phase 2, Active, not recruiting, 118 people, 27 Jul 2022

  • NCT05292664

    Collaborator, Phase 1, Recruiting, 30 people, 23 Mar 2022

  • NCT05288400

    Phase 3, Completed, 150 people, 21 Mar 2022

  • NCT05184842

    Collaborator, Phase 2, Recruiting, 91 people, 11 Jan 2022

  • NCT04894123

    Collaborator, Phase 2, Terminated, 1 person, 20 May 2021

  • NCT04617457

    Collaborator, Phase 2, Status unknown, 150 people, 5 Nov 2020

  • NCT04307576

    Collaborator, Phase 3, Recruiting, 6,430 people, 13 Mar 2020

  • NCT04306627

    Collaborator, Phase 4, Status unknown, 200 people, 13 Mar 2020

  • NCT03837977

    Collaborator, Phase 2, Completed, 58 people, 12 Feb 2019

  • NCT03764553

    Collaborator, Phase 2, Active, not recruiting, 320 people, 5 Dec 2018

  • NCT03117751

    Collaborator, Phase 2/3, Active, not recruiting, 790 people, 18 Apr 2017

  • NCT03044587

    Collaborator, Phase 2, Completed, 93 people, 7 Feb 2017

  • NCT03020030

    Collaborator, Phase 3, Active, not recruiting, 560 people, 13 Jan 2017

  • NCT01437371

    Collaborator, Phase 3, Completed, 35 people, 20 Sept 2011

Funded papers

Sources: api.crossref.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org